Daniel Marshall is the Senior Director of Global Oncology Search & Evaluation at AstraZeneca, leveraging a deep background in business development and venture capital. His career includes roles at MSD, Epidarex Capital, and IP Group plc. He holds a PhD in Immunology from University College London.
His PhD research was specifically focused on the role of NF-κB signalling in T-cell activation.
Daniel Marshall
Senior Director Global Oncology S&E at AstraZeneca
United Kingdom
Overview
Topics They Care About
Oncology Partnering
Actively seeks academic and biotech partners, frequently speaking on pharma partnering strategies and how to secure meetings at major industry conferences.
Biotech Investing
Has extensive experience in venture capital from his previous roles as a Senior Associate at Epidarex Capital and an Investment Manager at IP Group plc.
Immuno-Oncology
Holds a PhD in Immunology and, in a previous role, led searches for next-generation immuno-oncology research from academic and biotech innovators.
Media Appearances
Daniel has no verified media appearances
Work History
10-2025
Senior Director Global Oncology S&E at AstraZeneca
11-2021 - 10-2025
Director Oncology Business Development at MSD
5-2019 - 11-2021
Senior Associate at Epidarex Capital
12-2016 - 5-2019
Investment Manager at IP Group plc
9-2013 - 12-2016
Business Development/Diligence team at LifeArc
Education
2009 - 2013
PhD from UCL
2004 - 2008
Bsc from University of Bath
More Information
Social Presence :
Prographics :
Exp : 12
Location : United Kingdom
Job Level : Senior
Designation : Senior Director Global Oncology S&E at AstraZeneca
